Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (301-310 of 583) with videos related to

Pageof 59
Sort By:
Cancer Research|July 1, 1992
An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocationG Cimino, T Nakamura, Y Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B studyAndreas Neubauer, Kati Maharry, Krzysztof Mrózek, et al.
Cancer Treatment Reports|April 1, 1982
Effect of age on therapeutic response and survival in advanced Hodgkin's diseaseB A Peterson, T F Pajak, M R Cooper, et al.
Blood|January 11, 2000
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129J L Slack, C L Willman, J W Andersen, et al.
Cancer|September 16, 2004
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literatureWilliam Blum, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood|February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
Blood|April 13, 2016
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaDaniel A Arber, Attilio Orazi, Robert Hasserjian, et al.
Haematology and Blood Transfusion|January 1, 1985
Chromosome abnormalities in malignant lymphoma: biologic and clinical correlationsC D Bloomfield, D C Arthur, E G Levine, et al.
Leukemia Research|September 9, 2011
High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemiaAndrea Kühnl, Martin Kaiser, Martin Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251E J Lee, G R Petroni, C A Schiffer, et al.
Pageof 59

Showing results (301-310 of 583) with videos related to

Sort By:
Pageof 59
Cancer Research|July 1, 1992
An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocationG Cimino, T Nakamura, Y Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B studyAndreas Neubauer, Kati Maharry, Krzysztof Mrózek, et al.
Cancer Treatment Reports|April 1, 1982
Effect of age on therapeutic response and survival in advanced Hodgkin's diseaseB A Peterson, T F Pajak, M R Cooper, et al.
Blood|January 11, 2000
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129J L Slack, C L Willman, J W Andersen, et al.
Cancer|September 16, 2004
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literatureWilliam Blum, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood|February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
Blood|April 13, 2016
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaDaniel A Arber, Attilio Orazi, Robert Hasserjian, et al.
Haematology and Blood Transfusion|January 1, 1985
Chromosome abnormalities in malignant lymphoma: biologic and clinical correlationsC D Bloomfield, D C Arthur, E G Levine, et al.
Leukemia Research|September 9, 2011
High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemiaAndrea Kühnl, Martin Kaiser, Martin Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251E J Lee, G R Petroni, C A Schiffer, et al.
Pageof 59